UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus

Mayo Clinic proceedings, 2003-04, Vol.78 (4), p.447-456

Gerich, John E.

2003

Link zum Volltext

Verfügbarkeit prüfen

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, randomized, comparative trial

Diabetes care, 2005-07, Vol.28 (7), p.1630-1635

2005

Link zum Volltext

Verfügbarkeit prüfen

Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus

Expert review of clinical pharmacology, 2011-11, Vol.4 (6), p.669-683

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)

Diabetes care, 2013-10, Vol.36 (10), p.2945-2951

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin

Diabetes care, 2013-10, Vol.36 (10), p.2945-2951

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes

Diabetes research and clinical practice, 2007-08, Vol.77 (2), p.280-285

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy

Diabetes care, 2012-06, Vol.35 (6), p.1225-1231

2012

Link zum Volltext

Verfügbarkeit prüfen

Oral Hypoglycemic Agents

The New England journal of medicine, 1989-11, Vol.321 (18), p.1231-1245

Gerich, John E

1989

Link zum Volltext

Verfügbarkeit prüfen

Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors

Clinical cornerstone, 2007, Vol.8 (3), p.53-68

Gerich, John E.

2007

Link zum Volltext

Verfügbarkeit prüfen

Hypoglycemia: Acute and Chronic Complications of Diabetes

Endocrinology and metabolism clinics of North America, 2013, Vol.42 (4)

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Aging on Glucose Homeostasis

Diabetes care, 2008-03, Vol.31 (3), p.539-543

2008

Link zum Volltext

Verfügbarkeit prüfen

Role of the kidney in hyperglycemia in type 2 diabetes

Current diabetes reports, 2002-06, Vol.2 (3), p.237-241

2002

Link zum Volltext

Verfügbarkeit prüfen

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects

Diabetes care, 2005-07, Vol.28 (7), p.1630-1635

2005

Link zum Volltext

Verfügbarkeit prüfen

Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes

Diabetes (New York, N.Y.), 2003-06, Vol.52 (6), p.1386-1392

2003

Link zum Volltext

Verfügbarkeit prüfen

Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus

Comprehensive therapy, 2005, Vol.31 (2), p.106

2005

Link zum Volltext

Verfügbarkeit prüfen

Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect

Science (American Association for the Advancement of Science), 1973-10, Vol.182 (4108), p.171-173

1973

Link zum Volltext

Verfügbarkeit prüfen

Renal Gluconeogenesis

Diabetes care, 2001-02, Vol.24 (2), p.382-391

2001

Link zum Volltext

Verfügbarkeit prüfen

Reversal of Hypoglycemia Unawareness in a Long-Term Type 1 Diabetic Patient by Improvement of β-Adrenergic Sensitivity after Prevention of Hypoglycemia

The journal of clinical endocrinology and metabolism, 2000-02, Vol.85 (2), p.523-525

2000

Link zum Volltext

Verfügbarkeit prüfen

Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization

Diabetes (New York, N.Y.), 1982-08, Vol.31 (8 Pt 1), p.663

1982

Link zum Volltext

Verfügbarkeit prüfen

Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion

Diabetes (New York, N.Y.), 1983-02, Vol.32 (2), p.134

1983

Link zum Volltext

Verfügbarkeit prüfen

Commentary

Metabolism, clinical and experimental, 2003-11, Vol.52 (11), p.1524-1525

Gerich, John E.

2003

Link zum Volltext

Verfügbarkeit prüfen

Commentary

Metabolism, clinical and experimental, 2003-11, Vol.52 (11), p.1524-1525

Gerich, John E.

2003

Link zum Volltext

Verfügbarkeit prüfen

Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?

Diabetes (New York, N.Y.), 2002-02, Vol.51 (2), p.S117

Gerich, John E

2002

Link zum Volltext

Verfügbarkeit prüfen

Demonstration of a dawn phenomenon in normal human volunteers

Diabetes (New York, N.Y.), 1984-12, Vol.33 (12), p.1150

1984

Link zum Volltext

Verfügbarkeit prüfen

Glycemic and Blood Pressure Responses to Acute Doses of Rebaudioside A, a Steviol Glycoside, in Subjects with Normal Glucose Tolerance or Type 2 Diabetes Mellitus

The FASEB journal, 2009-04, Vol.23 (S1)

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 109

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(45)
Male
(32)
Adult
(27)
Female
(24)
Biological And Medical Sciences
(23)
Insulin - Blood
(20)
Medical Sciences
(20)
Blood Glucose - Metabolism
(18)
Endocrine Pancreas. Apud Cells
(16)
Endocrinopathies
(16)
Diabetes. Impaired Glucose Tolerance
(15)
Glucagon - Blood
(15)
Middle Aged
(13)
Blood Glucose - Analysis
(12)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(12)
Insulin
(12)
Animals
(11)
Diabetes
(11)
Glucose
(10)
Glucose - Metabolism
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, randomized, comparative trial

Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin

Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy

Oral Hypoglycemic Agents

Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors

Hypoglycemia: Acute and Chronic Complications of Diabetes

Effect of Aging on Glucose Homeostasis

Role of the kidney in hyperglycemia in type 2 diabetes

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects

Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes

Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus

Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect

Renal Gluconeogenesis

Reversal of Hypoglycemia Unawareness in a Long-Term Type 1 Diabetic Patient by Improvement of β-Adrenergic Sensitivity after Prevention of Hypoglycemia

Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization

Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion

Commentary

Commentary

Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?

Demonstration of a dawn phenomenon in normal human volunteers

Glycemic and Blood Pressure Responses to Acute Doses of Rebaudioside A, a Steviol Glycoside, in Subjects with Normal Glucose Tolerance or Type 2 Diabetes Mellitus

Aktive Filter

Suchergebnisse filtern